NRX Pharmaceuticals, Inc. (NRXP)
Nasdaq: NRXP · Pharmaceutical Preparations · Wilmington, DE · filing with the SEC since 2017
Who owns NRX Pharmaceuticals, Inc.
As filed with the SECHolders of 5% or more
1
The B Group, Inc. holds 12.6% of Common Stock, $0.001 par value, as its SCHEDULE 13G filed Aug 21, 2025 says.
Directors and officers
6
report now, of 27 people on the record since 2017. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
The B Group, Inc.
SCHEDULE 13G · filed Aug 21, 2025 · Common Stock, $0.001 par value
Anson Funds Management LP
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 9.3% in Aug 14, 2025
What NRXP reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Cohen LLC
An investee · investee · invested in, named in the 10-K filed Mar 23, 2026
Dura Medical
A company bought · acquisition · Aug 2025 · owns, named in the 10-K filed Mar 23, 2026
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 4, 2025 to Nov 4, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2024 runs to Nov 4, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.